Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant letrozole plus CAF chemotherapy for locally advanced breast cancer
ACTRN12608000523303Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer comparing CAF + letrozole with CAF + placebo (2 arms). Primary endpoint: Pathologic response rate. Started Oct 2008; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12608000523303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000523303.